SLC7A11 and non-small cell lung carcinoma: In TCGA data, the expression of SLC7A11 was markedly higher in NSCLC samples (Figure 1ap< 0.01), and this finding was corroborated by GEO dataset analysis (GSE33532, Figure 1b), further establishing SLC7A11 as a potential therapeutic target in NSCLC.